Indaptus Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Indaptus Therapeutics Operating Expenses Growth & History (INDP)
Indaptus Therapeutics's operating expenses was $19.8M for fiscal 2025.
View full Indaptus Therapeutics company overviewIndaptus Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $19.8M | $4.5M | +29.08% |
| 2024 | 2024-12-31 | $15.4M | −$1.0M | −6.18% |
| 2023 | 2023-12-31 | $16.4M | $1.5M | +9.84% |
| 2022 | 2022-12-31 | $14.9M | $7.2M | +92.92% |
| 2021 | 2021-12-31 | $7.7M | $4.1M | +114.74% |
| 2020 | 2020-12-31 | $3.6M | — | — |
Indaptus Therapeutics quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.8M | −$2.6M | −59.41% |
| Q1 2026 | 2026-03-31 | $2.2M | −$2.4M | −52.77% |
| Q4 2025 | 2025-12-31 | $8.2M | $4.0M | +95.51% |
| Q3 2025 | 2025-09-30 | $2.6M | −$493,570 | −15.71% |
| Q2 2025 | 2025-06-30 | $4.5M | $347,878 | +8.47% |
| Q1 2025 | 2025-03-31 | $4.6M | $629,320 | +15.96% |
| Q4 2024 | 2024-12-31 | $4.2M | −$8,064 | −0.19% |
| Q3 2024 | 2024-09-30 | $3.1M | −$1.1M | −26.04% |
| Q2 2024 | 2024-06-30 | $4.1M | $613,623 | +17.56% |
| Q1 2024 | 2024-03-31 | $3.9M | −$511,927 | −11.49% |
| Q4 2023 | 2023-12-31 | $4.2M | $92,610 | +2.27% |
| Q3 2023 | 2023-09-30 | $4.2M | $695,863 | +19.59% |
| Q2 2023 | 2023-06-30 | $3.5M | −$373,998 | −9.67% |
| Q1 2023 | 2023-03-31 | $4.5M | $1.1M | +30.95% |
| Q4 2022 | 2022-12-31 | $4.1M | $868,527 | +26.99% |
| Q3 2022 | 2022-09-30 | $3.6M | $184,558 | +5.48% |
| Q2 2022 | 2022-06-30 | $3.9M | $3.3M | +631.92% |
| Q1 2022 | 2022-03-31 | $3.4M | $2.8M | +454.11% |
| Q4 2021 | 2021-12-31 | $3.2M | — | — |
| Q3 2021 | 2021-09-30 | $3.4M | $1.8M | +117.79% |
| Q2 2021 | 2021-06-30 | $528,645 | — | — |
| Q1 2021 | 2021-03-31 | $613,975 | — | — |
| Q3 2020 | 2020-09-30 | $1.5M | — | — |
Indaptus Therapeutics operating expenses trends
Over the last five fiscal years, Indaptus Therapeutics's operating expenses increased from $3.6M to $19.8M, a change of $16.2M. The latest reported quarter, Q2 2026, shows $1.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indaptus Therapeutics source filings ↗